Anti-enolase-α autoantibodies in cancer-associated retinopathy: Epitope mapping and cytotoxicity on retinal cells

Journal of Autoimmunity

Volumn 11, Issue 6, 1998, Pages 671-677

  Adamus, G ^a   Amundson, D ^a   Seigel, G M ^b   MacHnicki, M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Apoptosis; CAR; Paraneoplastic syndrome; Peptide; Retina

Indexed keywords

AUTOANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; GENE MAPPING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL; RETINOPATHY;

EID: 0032440927     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0239     Document Type: Article

References (23)

1. Adamus G., Machnicki M., Seigel G.M. Apoptotic retinal cell death induced by autoantibodies of cancer associated retinopathy. Invest. Ophthalmol. Vis. Sci. 38:1997;283-291.
2. Thirkill C.E., Tait R.C., Tyler N.K., Roth A.M., Keltner J.L. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest. Ophthalmol. Vis. Sci. 33:1992;2768-2772.
3. Polans A.S., Buczylko J., Crabb J., Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J. Cell Biol. 112:1991;981-989.
4. Adamus G., Guy J., Schmied J.L., Arendt A., Hargrave P.A. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 34:1993;2626-2633.
5. Kornguth S.E., Kalinke T., Grunwald G.B., Schutta H., Dahl D. Anti-neurofilament antibodies in sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 46:1986;2588-2595.
6. Adamus G., Aptsiauri N., Guy J., Heckenlively J., Flannery J., Hargrave P.A. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin. Immunol. Immunopath. 78:1996;120-129.
7. Akoun G.M., Scarna H.M., Milleron B.J., Benichou M.P., Herman D.P. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest. 87:1985;39-43.
8. Carney D.N., Ihde D.C., Cohen M.H., Marangos P.J., Bunn Jr P.A., Minna J.D., Gazdar A.F. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1(8272):1982;583-585.
9. Gomm S.A., Keevil B.G., Thatcher N., Hasleton P.S., Swindell R.S. The value of tumour markers in lung cancer. Br. J. Cancer. 58:1988;797-804.
10. Ishiguro Y., Kato K., Shimizu A., Ito T., Nagaya M. High level of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma. Clin. Chim. Acta. 121:1982;173-180.
11. Seigel G.M. Establishment of an E1A-immortalized retinal cell line in vitro. Cell. Devel. Biol. 32:1996;66-68.
12. Adamus G., Aptsiauri N., Guy J., Heckenlively J.R., Hargrave P.A. Anti-enolase antibodies in paraneoplastic retinopathy. J. Immunol. 150:1993;74A.
13. Moodie F.D., Leaker B., Cambridge G., Totty N.F., Segal A.W. Alpha-enolase: a novel autoantigen in ANCA positive vasculitis. Kidney Int. 43:1993;675-681.
14. Walter M., Berg H., Leidenberger F.A., Schweppe K-W., Northermann W. Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis. J. Autoimmunity. 8:1995;931-945.
15. Akisawa N., Maeda T., Iwasaki S., Onishi S. Identification of an autoantibody against alpha enolase in primary biliary cirrhosis. J. Hepatol. 26:1997;845-851.
16. Gitlits V.M., Sentry J.W., Matthew M.L., Smith A.I., Toh B.H. Autoantibodies to evolutionary conserved epitopes of enolase in a patient with discoid lupus erythematosus. Immunology. 92:1997;362-368.
17. Tan E.M., Chan E.K.L. Molecular biology of autoantigens and new insights into autoimmunity. Clin. Invest. 71:1993;327-330.
18. Rattner J.B., Martin L., Waisman D.M., Johnstone S.A., Fritzler M.J. Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. J. Immunol. 146:1991;2341-2344.
19. Aaronson R.M., Graven K.K., Tucci M., McDonald R.J., Farber H.W. Non-neuronal enolase is an endothelial hypoxic stress protein. J. Biol. Chem. 46:1995;27752-27757.
20. Nakajima K., Hamanoue M., Takemoto N., Hattori T., Kato K., Kohsaka S. Plasminogen binds specifically to alpha enolase on rat neuronal plasma membrane. J. Neurochem. 63:1994;2048-2057.
21. Alexianu M.E., Mohamed A.H., Smith R.G., Colom L.V., Appel A.H. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J. Neurochem. 63:1994;2365-2368.
22. Greenlee J.E., Parks T.N., Jaeckle K.A. Type II (anti-Hu) anti-neuronal antibodies produce destruction of rat cerebellar granule neuronsin vitro. Neurology. 43:1993;2049-2054.
23. Hormigo A., Lieberman F. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity. J. Neuroimmunol. 55:1994;205-212.